Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8OM8

X-ray structure of lysozyme obtained upon reaction with [VIVO(empp)2] (Structure A)

This is a non-PDB format compatible entry.
Summary for 8OM8
Entry DOI10.2210/pdb8om8/pdb
DescriptorLysozyme C, ACETATE ION, tris-[(1-methyl-2-ethyl-3-hydroxy-4(1H)-pyridinone)]-V(V)3O7, ... (7 entities in total)
Functional Keywordsmetallodrugs, protein metalation, biologically active v compounds, metal-protein interactions, hydrolase
Biological sourceGallus gallus (chicken)
Total number of polymer chains1
Total formula weight15543.45
Authors
Paolillo, M.,Ferraro, G.,Merlino, A. (deposition date: 2023-03-31, release date: 2023-06-07, Last modification date: 2024-11-13)
Primary citationFerraro, G.,Paolillo, M.,Sciortino, G.,Pisanu, F.,Garribba, E.,Merlino, A.
Implications of Protein Interaction in the Speciation of Potential V IV O-Pyridinone Drugs.
Inorg.Chem., 62:8407-8417, 2023
Cited by
PubMed Abstract: Vanadium complexes (VCs) are promising agents for the treatment, among others, of diabetes and cancer. The development of vanadium-based drugs is mainly limited by a scarce knowledge of the active species in the target organs, which is often determined by the interaction of VCs with biological macromolecules like proteins. Here, we have studied the binding of [VO(empp)] (where Hempp is 1-methyl-2-ethyl-3-hydroxy-4(1)-pyridinone), an antidiabetic and anticancer VC, with the model protein hen egg white lysozyme (HEWL) by electrospray ionization-mass spectrometry (ESI-MS), electron paramagnetic resonance (EPR), and X-ray crystallography. ESI-MS and EPR techniques reveal that, in aqueous solution, both the species [VO(empp)] and [VO(empp)(HO)], derived from the first one upon the loss of a empp(-) ligand, interact with HEWL. Crystallographic data, collected under different experimental conditions, show covalent binding of [VO(empp)(HO)] to the side chain of Asp48, and noncovalent binding of -[VO(empp)(HO)], [VO(empp)(HO)], [VO(empp)(HO)], and of an unusual trinuclear oxidovanadium(V) complex, [VO(empp)(HO)], with accessible sites on the protein surface. The possibility of covalent and noncovalent binding with different strength and of interaction with various sites favor the formation of adducts with the multiple binding of vanadium moieties, allowing the transport in blood and cellular fluids of more than one metal-containing species with a possible amplification of the biological effects.
PubMed: 37195003
DOI: 10.1021/acs.inorgchem.3c01041
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.08 Å)
Structure validation

229380

PDB entries from 2024-12-25

PDB statisticsPDBj update infoContact PDBjnumon